Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 28.03MEnterprise Value
VS
Market
Sector
Industry
History
$ 0.32Close
$ 0.21 - $ 14.01 52-Week Range
Ticker Information
Ticker
ASBPCompany Name
ASPIRE BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQASPIRE BIOPHARMA HOLDINGS INC - Enterprise Value Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ASBP - EV Historical data
| Date | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
|---|---|---|---|---|
| 6/30/2025 | $ 206.23K | $ 8.47M | $ 28.03M | $ 19.76M |
| 3/31/2025 | $ 1.35M | $ 6.76M | $ 17.2M | $ 11.79M |
| 12/31/2024 | $ 3.63K | $ 1.27M | $ 26.2M | $ 24.94M |
| 9/30/2024 | $ 0 | $ 5.34M | $ 95.36M | $ 90.02M |
| 6/30/2024 | $ 0 | $ 5.36M | $ 92.56M | $ 87.2M |
| 3/31/2024 | $ 0 | $ 2M | $ 90.29M | $ 88.29M |
| 12/31/2023 | $ 0 | $ 12.38K | $ 99.37M | $ 99.35M |
| 9/30/2023 | $ 280 | $ 0 | $ 98.09M | $ 98.09M |
| 6/30/2023 | $ 125.2K | $ 0 | $ 94.73M | $ 94.86M |
| 3/31/2023 | $ 315.15K | $ 0 | $ 378.11M | $ 378.42M |
Key Performance Insights, Last 5 Years
- ASPIRE BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) EV stands at $ 0.
- Over the past 5 years, ASPIRE BIOPHARMA HOLDINGS INC's average EV has been $ 177.12M.
- The median EV for ASPIRE BIOPHARMA HOLDINGS INC during this period was $ 96.73M
- ASPIRE BIOPHARMA HOLDINGS INC reached its highest EV over the past 5 years at $ 378.11M.
- The lowest EV recorded by ASPIRE BIOPHARMA HOLDINGS INC in the same timeframe $ 17.2M
Similar metrics to Market Cap:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Enterprise Value
[Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].Market Cap + Debt - CashnEq
(=) EV EV for ASPIRE BIOPHARMA HOLDINGS INC is calculated as follows: Market Cap [ $ 0 ] + Debt [ $ 238.6K ] - CashnEq [ $ 0 ]
(=) EV [ $ 0 ] ASBP - Enterprise Value, Last 5 years
$ 17.2M
Minimum
Mar 31, 2025
$ 378.11M
Maximum
Mar 31, 2023
$ 177.12M
Average
$ 96.73M
Median
EV Benchmark AnalysisMarket
The chart above depicts the distribution of EV for companies in the Total Stock Market. The average EV of the companies is $ 1.25B with a standard deviation of $ 1.67B.
The following table provides additional summary stats:
EV in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | $ -1.69B |
| max | $ 6.88B |
| average | $ 1.25B |
| median | $ 439.6M |
| std | $ 1.67B |